A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Critical Negotiations Progress for Sh1.1 Trillion Adani Takeover of JKIA, CS Chirchir Comments
AC Milan Eyes Rashford Over Walker Amid Manchester United Transfer Talks
Ferdinand Omanyala's Victory at FBK Games Sets Stage for Paris Olympics Glory
Veteran Filmmaker Rakesh Roshan Retires from Directing, Teases 'Krrish 4' Updates
Megalie Mendes Discusses Fulham's Ambitions in Crucial Women's FA Cup Showdown
